Is SARS-CoV-2 screening still necessary before hematopoietic stem cell donation? Observations from a single center and review of the literature

Transfus Apher Sci. 2022 Oct;61(5):103448. doi: 10.1016/j.transci.2022.103448. Epub 2022 Apr 9.

Authors

Roberto Crocchiolo¹, Elisabetta Volpato², Laura Bellio², Irene Cuppari², Gabriele Magliano³, Beatrice De Marco³, Giovanni Grillo³, Silvano Rossini²

Affiliations

¹ Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy. Electronic address: roberto.crocchiolo@ospedaleniguarda.it.
² Servizio di Immunoematologia e Medicina Trasfusionale, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
³ Bone Marrow Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.

No abstract available

Keywords: Donor; Hematopoietic stem cells; Nasopharyngeal swab; SARS-CoV-2; Transplantation.

Publication types

Review
Letter

MeSH terms

COVID-19 Testing
COVID-19* / diagnosis
Hematopoietic Stem Cells
Humans
RNA, Viral
SARS-CoV-2*

Substances

RNA, Viral